about
Current and future treatment options in SIADHArginine Vasopressin and Copeptin in PerinatologyA Dormant Microbial Component in the Development of PreeclampsiaAmerican Society of Nephrology Quiz and Questionnaire 2015: Electrolytes and Acid-Base Disorders.Association of HPA axis hormones with copeptin after psychological stress differs by sexA novel AVP gene mutation in a Turkish family with neurohypophyseal diabetes insipidus.Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment.Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhageWater balance disorders after neurosurgery: the triphasic response revisitedCopeptin and Decline in Kidney FunctionRole of the Vasopressin/Apelin Balance and Potential Use of Metabolically Stable Apelin Analogs in Water Metabolism Disorders.The Circadian Rhythm of Copeptin, the C-Terminal Portion of Arginine Vasopressin.Circulating levels of copeptin, a novel biomarker in pre-eclampsia.Copeptin, IGFBP-1, and cardiovascular prognosis in patients with type 2 diabetes and acute myocardial infarction: a report from the DIGAMI 2 trial.Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension.Predictors of autosomal dominant polycystic kidney disease progressionCopeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney diseaseEndocrine dysfunction in sepsis: a beneficial or deleterious host response?Renal function interferes with copeptin in prediction of major adverse cardiac events in patients undergoing vascular surgery.Copeptin testing in acute myocardial infarction: ready for routine use?Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction.Changes in Plasma Copeptin Levels during Hemodialysis: Are the Physiological Stimuli Active in Hemodialysis Patients?Hyponatraemia in imported malaria: the pathophysiological role of vasopressinCoordinated Regulation of Vasopressin Inactivation and Glucose Uptake by Action of TUG Protein in Muscle.Cardiorenal biomarkers in acute heart failure.International spinal cord injury endocrine and metabolic extended data set.Effect of increased water intake on plasma copeptin in patients with chronic kidney disease: results from a pilot randomised controlled trial.Serum copeptin and pregnancy outcome in preeclampsiaRelationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohortChanges in copeptin and bioactive vasopressin in runners with and without hyponatremiaThe combination of high sensitivity troponin T and copeptin facilitates early rule-out of ACS: a prospective observational studyCopeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31).Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome.Unexplained Anemia in the Elderly: Potential Role of Arterial Stiffness.Biomarkers: a definite plus in pneumonia.Increased copeptin levels in metabolic syndrome from a Romanian population.Copeptin and its potential role in diagnosis and prognosis of various diseases.Prognostic role of copeptin with all-cause mortality after heart failure: a systematic review and meta-analysis.Diagnostic accuracy of copeptin sensitivity and specificity in patients with suspected non-ST-elevation myocardial infarction with troponin I below the 99th centile at presentation.Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome.
P2860
Q24652519-60CC53C2-563C-4B75-9115-060524E194D2Q26741093-B11AC6FE-E5D6-4308-9975-30EF62BBACD5Q28069689-63B6133E-0A9A-41BD-A474-0F00AF7C371FQ30277654-9133AB5C-945B-45E6-A9D5-0B60AF0A122AQ30693052-BA8EF7CD-8B7D-41DF-A9AE-0A60027342F6Q30982488-A8621E09-F48F-4DBB-990E-0509968F6E62Q31154416-C784FDEB-C997-49A8-B235-FE019BC30CE1Q33588084-6D9D0488-3ABB-42CE-B35B-0B887D3979F8Q33597423-D30FD880-D14E-4070-B1E5-AFD06F01D028Q33613314-E90BC132-AAAD-4E5C-BE8E-D9A6DE7D8FFFQ33742305-97477490-3298-4EDB-9230-8910F55F35C2Q33800762-273EDA43-F36F-401E-977E-8A81ED93E421Q33875627-9A31BD5A-C6C4-450D-8184-FFBA6DB829E5Q33932812-04D3DCDE-5EDE-4569-B9F3-79BE178B60F5Q34248479-C8EBD3D0-DE24-4CA3-8A21-4F82949A07E3Q34427678-8C5C3167-F562-4204-92AE-ABF136951FDEQ34639667-26CBB7DC-3B45-4C58-96BA-1CBAF13C6C3CQ35151275-E8E6B351-EFD0-4EB0-BFBC-39A5E01B4765Q35392693-1218FCA1-DF60-434F-94FD-E5B8532B1A09Q35556651-0A256726-2E8E-4A1E-8CDF-0B4940BD11BCQ35569452-517E738D-F213-4372-85B3-D0A99CC4F6D3Q35606726-6A2A6A27-70D0-4882-AF27-BF10D33EB0DDQ35812014-E67B68C0-61F6-4C23-B660-0ED5F4399FBCQ35860779-C252F473-97D8-4A6E-996F-365314F19566Q36313675-01E79CB0-3961-4C30-BBA4-2B39135A83EDQ36315948-51311BB4-CCA8-4E5E-91C0-BB6CB163F643Q36329310-CBCC1A86-1DB9-46B3-9BEF-F01234955C81Q36423734-DD4170D2-C565-48B8-8231-08CA9ACA7986Q36616057-B3B7F897-4B06-41F2-80D4-D0BF1656C4F7Q36949164-2D6FEAF3-C2C7-45DC-8058-4FE7F77A00E1Q36972479-B3E33BD6-0FAE-497C-9432-3591ABCE6B4CQ37193463-160FE565-FF1D-48B8-812D-E6CCEC4E479AQ37257539-CCABBA68-1319-47E8-A422-90AB3863297DQ37363807-62A3CFDF-2410-4B86-97C0-833D4D80ADC6Q37450352-4A83AB6E-D24D-464F-9D5B-6A43402CB49BQ37479457-43476802-E5AF-4000-8565-CEF041002587Q37508425-F43AB04F-8661-49B3-B48E-BB4A09A7363BQ37573138-D824EDF2-7B6A-42C5-AB5B-75985686CA6EQ37684756-4E4B24A4-BF6E-42BE-86A2-574023874DA5Q37716537-9F12A3A3-B32A-429E-819E-7DD55A822404
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Copeptin: clinical use of a new biomarker.
@ast
Copeptin: clinical use of a new biomarker.
@en
Copeptin: clinical use of a new biomarker.
@nl
type
label
Copeptin: clinical use of a new biomarker.
@ast
Copeptin: clinical use of a new biomarker.
@en
Copeptin: clinical use of a new biomarker.
@nl
prefLabel
Copeptin: clinical use of a new biomarker.
@ast
Copeptin: clinical use of a new biomarker.
@en
Copeptin: clinical use of a new biomarker.
@nl
P2093
P1476
Copeptin: clinical use of a new biomarker.
@en
P2093
Joachim Struck
Martin W Dünser
Nils G Morgenthaler
Stefan Jochberger
P356
10.1016/J.TEM.2007.11.001
P577
2008-03-01T00:00:00Z